LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc. |
| November 11, 2021 | November 2021 Bond Updates |
|
SEATTLE, Nov. 11, 2021 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced its entry into a definitive merger agreement with Diopsys, Inc., a leader in modern visual... |
| View more at: https://www.prnewswire.com:443/news-releases/lumithera-inc-announces-creation-of-a-light-based-theranostic-approach-to-treat-ocular-disease-with-acquisition-of-diopsys-inc-301421902.html |
| Related News |
|